I have cleared GPAT 2020,2021, and NIPER 2021 with AIR 263. Being entered into Regulatory Affairs Specialization in NIPER, I have gone through various sections of ICH CTD Modules, especially 3.2.S & 3.2.P and Regulation of different highly regulated markets like US, EU, JAPAN, and CANADA. In addition to regulatory, I got an opportunity to explore Intellectual Property regarding para filings, Indian IP regulations, and slight touch based on the US, EU, and China.In the meantime, along with my Ph.D. guide, I have published an article in Pharmaceutical Patent analyst as a coauthor and published a book chapter titled Barriers to Marketing Authorization of Nanotechnology as a first author.